Skip to content
← Full study record

NCT03739684 · FLOW

Participant flow

Study of 18F-DCFPyL PET/CT Imaging in Patients With Suspected Recurrence of Prostate Cancer · Source last updated 2021-06-14

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups
  1. description
    Participants with suspected recurrence of prostate cancer and negative or equivocal findings per institutional standard of care conventional imaging were enrolled to receive a single dose of 9 mCi (333 MBq) 18F-DCFPyL injection followed by a single PET/CT scan acquired 1 to 2 hours post-dosing.
    id
    FG000
    title
    18F-DCFPyL Injection
periods
  1. milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        208
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        195
      type
      COMPLETED
    3. achievements
      1. group Id
        FG000
        num Subjects
        13
      type
      NOT COMPLETED
    title
    Overall Study
Complete source fields
groups
  1. description
    Participants with suspected recurrence of prostate cancer and negative or equivocal findings per institutional standard of care conventional imaging were enrolled to receive a single dose of 9 mCi (333 MBq) 18F-DCFPyL injection followed by a single PET/CT scan acquired 1 to 2 hours post-dosing.
    id
    FG000
    title
    18F-DCFPyL Injection
periods
  1. milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        208
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        195
      type
      COMPLETED
    3. achievements
      1. group Id
        FG000
        num Subjects
        13
      type
      NOT COMPLETED
    title
    Overall Study

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice